Summary
Activation of Met by its ligand HGF has been shown to elicit both mitogenic and motogenic responses in thyrocytes in vitro. In the present study we have investigated the expression of Met in human anaplastic thyroid carcinoma cells in culture. There was a variation in expression level and size of Met in the different cell lines; high Met expression was found in four cell lines, compared to non-neoplastic human thyrocytes. Treatment with glucoproteinase F showed that the size differences observed were due to variances in the degree of glycosylation. Interestingly, in cell lines with high expression of Met, the receptor proteins were found to be constitutively tyrosine phosphorylated. None of these cell lines expressed HGF mRNA, and addition of suramin did not affect the level of tyrosine phosphorylation of Met in unstimulated cells, suggesting the absence of autocrine stimulatory pathways. Furthermore, we did not observe MET gene amplification, activating mutations or phosphatase defects. The tyrosine phosphorylated receptors appeared functionally active since the receptors associated with the adaptor molecule Shc. In summary, we have found ligand-independent constitutively activated Met in four out of six anaplastic thyroid carcinoma cell lines.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adams, J. C., Furlong, R. A. & Watt, F. M. (1991). Production of scatter factor by ndk, a strain of epithelial cells, and inhibition of scatter factor activity by suramin. J Cell Sci 98: 385–394.
Ain, K. B. & Taylor, K. D. (1994). Somatostatin analogs affects proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 78: 1097–1102.
Auffray, C. & Rougeon, F. (1980). Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107: 303–314.
Bardelli, A., Maina, F., Gout, I., Fry, M. J., Waterfield, M. D., Comoglio, P. M. & Ponzetto, C. (1992). Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains. Oncogene 7: 1973–1978.
Bardelli, A., Ponzetto, C. & Comoglio, P. M. (1994). Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering. J Biotechnol 37: 109–122.
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, AM-L, Kmiecik, T. E., Vande Woude, G. F. & Aaronson, S. A. (1991). Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802–804.
Börset, M., Lien, E., Espevik, T., Helseth, E., Waage, A. & Sundan, A. (1996). Concomitant expression of hepatocyte growth factor/scatter factor and its receptor in human myeloma cell lines. J Biol Chem 271: 24655–24661.
Carlsson, J., Nilsson, K., Westermark, B., Pontén, J., Sundström, C., Larsson, E., Bergh, J., Påhlman, S., Busch, C. & Collins, V. P. (1983). Formation and growth of multicellular spheroids of human origin. Int J Cancer 31: 523–533.
Carcangiu, M. L., Steeper, T., Zampi, G. & Rosai, J. (1985). Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 83: 135–158.
de Juan, C., Sánchez, A., Nakamura, T., Fabregat, I. & Benito, M. (1994). Hepatocyte growth factor up-regulates met expression in rat fetal hepatocytes in primary culture. Biochem Biophys Res Commun 204: 1364–1370.
Di Renzo, M. F., Narsimhan, R. P., Olivero, M., Bretti, S., Giordano, S., Medico, E., Gaglio, P., Zara, P. & Comoglio, P. M. (1991). Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6: 1997–2003.
Di Renzo, M. F., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., Pierotti, M. A. & Comoglio, P. M. (1992). Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7: 2549–2553.
Di Renzo, M. F., Olivero, M., Katsaros, D., Crepaldi, T., Gaglia, P., Zola, P., Sismondi, P. & Comoglio, P. M. (1994). Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer 58: 658–662.
Di Renzo, M. F., Poulsom, R., Olivero, M., Comoglio, P. M. & Lemoine, N. R. (1995a). Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55: 1129–1138.
Di Renzo, M. F., Olivero, M., Serini, G., Orlandi, F., Pilotti, S., Belfiori, A., Costantino, A., Vigneri, R., Angeli, A., Pierotti, M. A. & Comoglio, P. M. (1995b). Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium. J Endocrinol Invest 18: 134–139.
Dremier, S., Taton, M., Coulonval, K., Nakamura, T., Matsumoto, K. & Dumont, J. E. (1994). Mitogenic, de-differentiating, and scattering effects of hepatocyte growth factor on dog thyroid cells. Endocrinology 135: 135–140.
Eccles, N., Ivan, M. & Wynford-Thomas, D. (1996). Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor. Mol Cell Endocrinol 117: 247–251.
Ferracini, R., Di Renzo, M. F., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P. L., Cremona, O., Campanacci, M. & Comoglio, P. M. (1995). The Met/HGF paracrine or an autocrine circuit. Oncogene 10: 739–749.
Fixman, E. D., Fournier, T. M., Kamikura, D. M., Naujokas, M. A. & Park, M. (1996). Pathways downstream of Shc and Grb2 are required for cell transformation by the Tpr–Met oncoprotein. J Biol Chem 271: 13116–13122.
Gambarotta, G., Boccacio, C., Giordano, S., Ando, M., Stella, M. C. & Comoglio, P. M. (1996). Ets up-regulates MET transcription. Oncogene 13: 1911–1917.
Giordano, S., Di Renzo, M. F., Narsimhan, R. P., Cooper, C. S., Rosa, C. & Comoglio, P. M. (1989). Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 4: 1383–1388.
Heldin, N-E & Westermark, B. (1988). Epidermal growth factor, but not thyrotropin, stimulates the expression of c-fos and c-myc messenger ribonucleic acid in porcine thyroid follicle cells in primary culture. Endocrinology 122: 1042–1046.
Heldin, N-E, Cvejic, D., Smeds, S. & Westermark, B. (1991). Coexpression of functionally active receptors for thyrotopin and platelet derived growth factor in human thyroid carcinoma cells. Endocrinology 129: 2187–2193.
Heldin, N-E, Gustavsson, B., Claesson-Welsh, L., Hammacher, A., Mark, J., Heldin, C-H & Westermark, B. (1988). Aberrant expression of receptors for platelet derived growth factor in an anaplastic thyroid carcinoma cell line. Proc Natl Acad Sci USA 85: 9302–9306.
Higashio, K., Shima, N., Goto, M., Itagaki, Y., Nagao, M., Yasuda, H. & Morinaga, T. (1990). Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Bichem Biophys Res Commun 170: 397–404.
Ivan, M., Bond, J. A., Prat, M., Comoglio, P. M. & Wynford-Thomas, D. (1997). Activated ras and ret oncogenes induce overexpression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene 14: 2417–2423.
Jeffers, M., Schmidt, L., Nakaigawa, N., Webb, C. P., Weirich, G., Kishida, T., Zbar, B. & Vande Woude, G. F. (1997). Activating mutations for the Met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 94: 11445–11450.
Longati, P., Bardelli, A., Ponzetto, C., Naldini, L. & Comoglio, P. M. (1994). Tyrosines1234–1235 are critical for the activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9: 49–57.
Naldini, L., Weidner, K. M., Vigna, E., Guadino, G., Bardelli, A., Ponzetto, C., Narsimham, R. P., Hartmann, G., Zarnegar, R., Michalopoulos, G. K., Birchmeier, W. & Comoglio, P. M. (1991). Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10: 2867–2878.
Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K. & Shimizu, S. (1989). Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440–443.
Ponzetto, C., Bardelli, A., Zhen, Z., Maina, F., dalla Zonca, P., Giordano, S., Graziani, A., Panayotou, G. & Comoglio, P. M. (1994). A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77: 261–271.
Ponzetto, C., Giordano, S., Peverali, F., Della Valle, G., Abate, M., Vaula, G. & Comoglio, P. M. (1991). c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 6: 553–559.
Prat, M., Narsimhan, R., Crepaldi, T., Nicotra, R., Natali, P. G. & Comoglio, P. M. (1991). The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49: 323–328.
Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S. & Vande Woude, G. F. (1992). Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol 12: 5152–5158.
Rong, S., Segal, S., Anver, M., Resau, J. H. & Vande Woude, G. F. (1994). Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 91: 4731–4735.
Rubin, J. S., Chan, A. M., Bottaro, D. P., Burgess, W. H., Taylor, W. G., Cech, A. C., Hirschfield, D. W., Wong, J., Miki, T., Finch, P. W. & Aaronsson, S. A. (1991). A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 88: 415–419.
Rusciano, D., Lorenzoni, P. & Burger, M. M. (1996). Constitutive activation of c-Met in liver metastatic B16 melanoma cells depends on both substrate adhesion and cell density and is regulated by a cytosolic tyrosine phosphatase activity. J Biol Chem 271: 20763–20769.
Santoro, M., Carlomagno, F., Romano, A., Bottaro, D. P., Dathan, N. A., Grieco, M., Fusco, A., Vecchio, G., Matoskova, B., Kraus, M. H. & Di Fiore, P. P. (1995). Activation of Ret as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267: 381–383.
Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., Allikmets, R., Chidambaram, A., Bergerheim, U. R., Feltis, J. T., Casadevall, C., Zamarron, A., Bernues, M., Richard, S., Lips, C. J., Walther, M. M., Tsui, L. C., Geil, L., Orcutt, M. L., Stackhouse, T., Lipan, J., Slife, L., Brauch, H., Decker, J., Niehans, G., Hughson, M. D., Moch, H., Storkel, S., Lerman, M. I., Linehan, W. M. & Zbar, B. (1997). Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68–73.
Scotlandi, K., Baldini, N., Oliviero, M., Di Renzo, M. F., Martana, M., Manara, M. C., Comoglio, P. M. & Ferracini, R. (1996). Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. Am J Pathol 149: 1209–1219.
Stoker, M., Gherardi, E. & Gray, J. (1987). Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239–242.
Tsao, M-S, Zhu, H., Giaid, A., Viallet, J., Nakamura, T. & Park, M. (1993). Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth & Diff 4: 571–579.
Tso, J. Y., Sun, X. H., Kao, T., Reece, K. S. & Wu, R. (1985). Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13: 2485–2502.
Tuck, A. B., Park, M., Sterns, E. E., Boag, A. & Elliott, B. E. (1996). Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 148: 225–232.
Villa-Moruzzi, E., Lapi, S., Prat, M., Gaudino, G. & Comoglio, P. M. (1993). A protein tyrosine phosphatase activity associated with the hepatocyte growth factor/scatter factor receptor. J Biol Chem 268: 18176–18180.
Weidner, K. M., Arakaki, N., Hartmann, G., Vandekerckhove, J., Weingart, S., Rieder, H., Fonatsch, C., Tsubouchi, H., Hishida, T., Daikuhara, Y. & Birchmeier, W. (1991). Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001–7005.
Weidner, K. M., Di Cesare, S., Sachs, M., Brinkmann, V., Behrens, J. & Birchmeier, W. (1996). Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384: 173–176.
Westermark, K., Karlsson, F. A. & Westermark, B. (1983). Epidermal growth factor modulates thyroid growth and function in culture. Endocrinology 112: 1680–1686.
Zarnegar, R. & Michalopoulos, G. K. (1995). The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177–1180.
Zarnegar, R., Muga, S., Rahija, R. & Michalopoulos, G. (1990). Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes. Proc Natl Acad Sci USA 87: 1252–1256.
Zhen, Z., Giordano, S., Longati, P., Medico, E., Campiglio, M. & Comoglio, P. M. (1994). Structural and functional domains critical for constitutive activation of the HGF-receptor. Oncogene 9: 1691–1697.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Bergström, J., Hermansson, A., Ståhl, T. et al. Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture. Br J Cancer 80, 650–656 (1999). https://doi.org/10.1038/sj.bjc.6690406
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690406
